On November 24, 2023, Bioventures 2014 L.P. Mpm, a significant shareholder of Werewolf Therapeutics, Inc. (NASDAQ: HOWL), sold 88,802 shares of the company. The shares were...
Aclarion, Inc. (NASDAQ: ACON), a healthcare technology company, is currently assessing its standing among competitors in the Medical Services industry. This analysis evaluates Aclarion’s performance in...
Aclarion, Inc. (NASDAQ: ACON) has emerged as a notable player in the “Medical Services” sector, which comprises 93 publicly traded companies. A recent financial survey provides...
The Yale chapter of Delta Sigma Theta Sorority, Inc. recently engaged the community with a week-long series of events known as the “REDaissance,” celebrating its annual...
On October 14, 2023, community members gathered for a food drive organized by SOS, Inc. in partnership with Walmart, successfully collecting essential items to assist families...
Castle Biosciences, Inc. has announced significant findings regarding its TissueCypher® Barrett’s Esophagus test, which offers crucial insights into patient risk that extend beyond traditional pathology. The...
Cogent Biosciences, Inc. has presented updated preclinical data on its pan KRAS(ON) inhibitor during a poster session at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets...
Cardio Diagnostics Holdings, Inc. has announced a significant expansion of its provider network, adding 15 new medical organizations from various regions across the United States. This...
Spero Therapeutics, Inc. and GSK plc have announced promising results from the pivotal Phase 3 PIVOT-PO trial for **tebipenem HBr**, an investigational oral antibiotic aimed at...
SpringWorks Therapeutics, Inc. has published new long-term efficacy and safety data from the Phase 3 DeFi trial of OGSIVEO® (nirogacestat). This oral gamma secretase inhibitor is...
